Origin Therapeutics Holdings (XCNQ:ORIG) Change In Receivables : C$-0.03 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Change In Receivables?

Origin Therapeutics Holdings's change in receivables for the quarter that ended in Jun. 2023 was C$-0.03 Mil. It means Origin Therapeutics Holdings's Accounts Receivable increased by C$0.03 Mil from Mar. 2023 to Jun. 2023 .

Origin Therapeutics Holdings's change in receivables for the fiscal year that ended in Sep. 2022 was C$0.00 Mil. It means Origin Therapeutics Holdings's Accounts Receivable declined by C$0.00 Mil from Sep. 2021 to Sep. 2022 .

Origin Therapeutics Holdings's Accounts Receivable for the quarter that ended in Jun. 2023 was C$0.07 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Origin Therapeutics Holdings's liquidation value for the three months ended in Jun. 2023 was C$3.01 Mil.

Origin Therapeutics Holdings Change In Receivables Historical Data

The historical data trend for Origin Therapeutics Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Change In Receivables Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Change In Receivables

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Change In Receivables	Get a 7-Day Free Trial				-0.02	0.04	-0.01	-0.03	-0.03

Origin Therapeutics Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03 Mil.

Origin Therapeutics Holdings (XCNQ:ORIG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Origin Therapeutics Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.071	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Origin Therapeutics Holdings's accounts receivable are only considered to be worth 75% of book value:

Origin Therapeutics Holdings's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3.065	-	0.11	+	0.75 * 0.071	+	0.5 * 0
=	3.01

Origin Therapeutics Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.